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Background
We conduct a phase 1 clinical trial where forty healthy vol-
unteers are immunized with multigene, multiclade HIV
DNA plasmids encoding nine different proteins of HIV-1
subtypes.
Materials and methods
Total nucleic acid was extracted from plasma or sera. A
nested PCR was performed using specific primers
designed for the vaccine plasmids and HIV-1 DNA PCR
directed against HIV genes not present in the vaccine.
Results
Two months after the third immunization, an HIV RNA
quantitative PCR was performed to confirm the non-
infected status of the participants. In half of the vaccines,
in total receiving 3–12 mg plasmid DNA, we noted reac-
tions of plasmid DNA or values corresponding to 20–
1200 HIV RNA copies in the Roche Amplicor assay. Env
and/or gag encoding plasmids were detected in the
plasma or serum of the vaccines, but no HIV. A PCR for
HIV protease (the protease gene is not included in the vac-
cine) was negative in all cases. Antigen and antibody
assays have confirmed that the individuals were not
infected. The study is still blinded, but a total of over 90%
have responded very well by T-cell assays.
Conclusion
HIV vaccine plasmids given id or im were identified as late
as two months after immunization. A relation between
immunogenicity and circulating vaccine plasmids will be
sought. DNA plasmids may give positive signals in a
standard HIV RNA quantative assay.
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